Dairy Giant New Zealand Endures Butter Price Shock
The dairy price shock spreads as far as cheese and milk, leading one economist to suggest locals face the grim prospect of cereal without milk if they want to save money.
Butter prices leapt 46.5 percent in the year to June to an average of NZ$8.60 (US$5.09) for a 500-gram (1.1-pound) block, according to official data from Stats New Zealand.
Milk prices surged 14.3 percent over the same period, while cheese shot up 30 percent.
High dairy prices have hit the headlines in New Zealand, with media outlet Stuff reporting that "exorbitant" prices are unlikely to "melt away" any time soon.
Wholesale and retail store Costco restricted butter sales to a maximum of 30 blocks per customer in June, but still sold out, according to the New Zealand Herald.
The prices are hurting consumers, said independent economist Brad Olsen, chief executive of Infometrics.
"At the moment, I'm going with any other alternative I can find," Olsen said of butter prices.
"I'd also say, the cheap option for breakfast at the moment seems to be to try cereal without the milk."
The phenomenon was driven by international prices and demand, Olsen said.
Butter supplies had failed to keep up with rising demand over the past two years, he said.
"New Zealand exports the vast majority of our dairy products. So if you're a company that's exporting butter, you've got to make a decision. Do you sell it at the international price overseas, or do you sell it cheaper in New Zealand?" the economist said.
"No business is going to sell it cheaper... if they can get a better price overseas."
But while New Zealand consumers were feeling the price pinch, the overall economy was benefiting as exporters creamed off larger profits from sales overseas.
"The sort of returns that our farmers and the primary sector more broadly are getting, and the economic benefit that brings, is actually far more substantial," Olsen said.
"It's an extra NZ$4.6 billion (US$2.7 billion) that has been flowing into the economy from the higher dairy payout. That's a significant boost."
New Zealand butter lovers are actually faring better than some, he said, adding they still pay 46 percent less than Americans. While New Zealand consumers are feeling the dairy price pinch, the overall economy is benefiting as exporters cream off larger profits from sales overseas. AFP
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Int'l Business Times
a day ago
- Int'l Business Times
US Migrant Raids Spark Boom For Private Detention Providers
Donald Trump's promise to carry out the largest deportation operation in US history has appalled some Americans. But others are cashing in on the boom in demand for private detention centers. Migrants captured by Immigration and Customs Enforcement agents need to be temporarily housed in places like the facility being readied in California City, prior to deportation. "When you talk to the majority of residents here, they have a favorable perspective on it," said Marquette Hawkins, mayor of the hardscrabble settlement of 15,000 people, 100 miles (160 kilometres) north of Los Angeles. "They look at the economic impact, right?" California City is to be home to a sprawling detention center that will be operated by CoreCivic, one of the largest companies in the private detention sector. The company, which declined AFP requests for an interview, says the facility would generate around 500 jobs, and funnel $2 million in tax revenue to the city. "Many of our residents have already been hired out there to work in that facility," Hawkins told AFP. "Any revenue source that is going to assist the town in rebuilding itself, rebranding itself, is going to be seen as a plus," he said. Trump's ramped-up immigration arrests, like those that provoked protests in Los Angeles, saw a record 60,000 people in detention in June, according to ICE figures. Those same figures show the vast majority have no conviction, despite the president's election campaign promises to go after hardened criminals. More than 80 percent of detainees are in facilities run by the private sector, according to the TRAC project at Syracuse University. And with Washington's directive to triple the number of daily arrests -- and $45 billion earmarked for new detention centers -- the sector is looking at an unprecedented boom. "Never in our 42-year company history have we had so much activity and demand for our services as we are seeing right now," Damon Hininger, executive director of CoreCivic, said in a May call with investors. When Trump took office in January, some 107 centers were operating. The number now hovers around 200. For Democratic politicians, this proliferation is intentional. "Private prison companies are profiting from human suffering, and Republicans are allowing them to get away with it," Congresswoman Norma Torres told reporters outside a detention center in the southern California city of Adelanto. At the start of the year, there were three people detained there; there are now hundreds, each one of them attracting a daily stipend of taxpayer cash for the operator. Torres was refused permission to visit the facility, run by the privately owned GEO Group, because she had not given seven days' notice, she said. "Denying members of Congress access to private detention facilities like Adelanto isn't just disrespectful, it is dangerous, it is illegal, and it is a desperate attempt to hide the abuse happening behind these walls," she said. "We've heard the horrifying stories of detainees being violently arrested, denied basic medical care, isolated for days, and left injured without treatment," she added. Kristen Hunsberger, a staff attorney at the Law Center for Immigrant Advocates, said one client complained of having to wait "six or seven hours to get clean water." It is "not sanitary and certainly not... in compliance with just basic human rights." Hunsberger, who spends hours on the road going from one center to another to locate her clients, says many have been denied access to legal counsel, a constitutional right in the United States. Both GEO and ICE have denied allegations of mistreatment at the detention centers. "Claims there is overcrowding or subprime conditions in ICE facilities are categorically FALSE," said Tricia McLaughlin, the assistant secretary at the Department of Homeland Security. "All detainees are provided with proper meals, medical treatment and have opportunities to communicate with their family members and lawyers." But some relatives of detainees tell a different story. Alejandra Morales, an American citizen, said her undocumented husband was detained incommunicado for five days in Los Angeles before being transferred to Adelanto. In the Los Angeles facility, "they don't even let them brush their teeth, they don't let them bathe, nothing. They have them all sleeping on the floor, in a cell, all together," she said. Hunsberger said that for detainees and their relatives, the treatment appears to be deliberate. "They're starting to feel that this is a strategy to wear people down, to have them in these inhumane conditions, and then pressure them to sign something where they could then agree to being deported," she said. The California City Immigration Processing Center in the Mojave Desert north of Los Angeles awaits reopening as a privately operated immigrant detention facility AFP
Int'l Business Times
4 days ago
- Int'l Business Times
Trump Admin Unveils AI Strategy To Maintain US Dominance
President Donald Trump's administration unveiled an aggressive, low-regulation strategy on Wednesday boosting big tech's race to stay ahead of China on artificial intelligence and cement US dominance in the fast-expanding field. The 25-page "America's AI Action Plan" outlines three aims: accelerating innovation, building infrastructure, and leading internationally on AI. Overall, the administration frames AI advancement as critical to maintaining economic and military supremacy. Environmental consequences in the planning document are sidelined. "We believe we're in an AI we want the United States to win that race," said the White House's AI point person David Sacks in a call with reporters. Trump was expected to formally announce the plan at an event later Wednesday and sign a series of executive orders to give key components of the strategy additional legal weight. In its collection of more than 90 government proposals, the plan calls for sweeping deregulation, with the administration promising to "remove red tape and onerous regulation" that could hinder private sector AI development. Much of that work has already been carried out through a Trump executive order repealing the AI policies of the Biden administration. The plan also asked the Federal Communications Commission to find ways to legally stop US states from implementing their own AI regulations and threatened to rescind federal aid to states that did so. The American Civil Liberties Union warned this would thwart "initiatives to uphold civil rights and shield communities from biased AI systems in areas like employment, education, health care, and policing." The Trump action plan also calls for AI systems to be "free from ideological bias" and designed to pursue objective truth rather than what the administration calls "social engineering agendas." This criterion would apply to AI companies wanting to do business with the US government. A senior White House official said the main target was AI models that gave attention to diversity and inclusion concerns in programming their model output -- reflecting the Trump administration's anti-"woke" agenda. A major focus in the plan involves building AI infrastructure, including streamlined permitting for data centers and energy facilities that would overlook environmental concerns to build as swiftly as possible. AI "challenges America to build vastly greater energy generation than we have today," the plan said. The administration, which largely rejects international science showing a growing climate crisis, proposes creating new environmental review exemptions for data center construction and expanding access to federal lands for AI infrastructure development. Addressing fears that AI will replace humans and create mass job losses across entire sectors, the administration's plan says instead that "AI will improve the lives of Americans by complementing their work -- not replacing it." The strategy calls for efforts to "counter Chinese influence in international governance bodies" and strengthen export controls on advanced AI computing technology. The plan also proposes evaluating Chinese AI models "for alignment with Chinese Communist Party talking points and censorship." At the same time, the strategy calls on the government to champion US technology in conquering overseas markets. These plans will help "ensure America sets the technological gold standard worldwide, and that the world continues to run on American technology," US Secretary of State Marco Rubio said in a statement. Critics of the plan said the policies were a gift to US tech giants that were scaling back their goals for zero carbon emissions in order to meet the acute computing needs for AI. "The AI Action Plan is yet another gift to Big Tech that clearly shows the Trump administration is again placing corporate interests ahead of the needs of everyday Americans," said Alan Butler of the Electronic Privacy Information Center.
Int'l Business Times
6 days ago
- Int'l Business Times
AstraZeneca To Invest $50 Bn In The US As Tariff Threat Looms
British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States by 2030 amid Donald Trump's threats to impose tariffs on the sector. The funds will boost its manufacturing and research operations in the US, including the construction of a multi-billion-dollar factory in Virginia, the company said in a statement. "Today's announcement underpins our belief in America's innovation in biopharmaceuticals," chief executive Pascal Soriot said in a statement. US President Donald Trump has opened the door to potential tariffs targeting pharmaceuticals, which had up to now benefited from exemptions to his sweeping levies on imports from trading partners. He ordered an investigation into pharmaceutical imports, suggesting that levies could reach up to 200 percent. The United States is a key market for the pharmaceutical industry, and AstraZeneca said it expects 50 percent of its revenue to come from the US by 2030. AstraZeneca has already begun transferring part of its European production to the United States, it announced in April. While the drugmaker could become exposed to US levies on its European-made products, Soriot has said that the impact would be limited due to the ongoing shift in production. Other major pharmaceutical companies, which had been exempt from tariffs for 30 years, have in recent months begun shifting investment and production to the United States. Swiss pharmaceutical giants Roche and Novartis and France's Sanofi have all announced multi-billion-dollar investments in the US. "For decades, Americans have been reliant on foreign supply of key pharmaceutical products," US Commerce Secretary Howard Lutnick said in a statement. He added that the new tariffs are focused on "ending this structural weakness". Tuesday's announcement included a new factory in Virginia, which will be the company's "largest single manufacturing investment". It adds to AstraZeneca's previously announced $3.5 billion investment in the US by 2026. "Soriot implied... that AstraZeneca wasn't wedded to a particular country and that it would invest wherever it made financial sense," said AJ Bell investment director Russ Mould. However, he noted that "the more business it does in the country, the greater the likelihood that investors might push for AstraZeneca to switch its main stock listing to the US." The pharmaceutical company abandoned plans earlier in the year to build a GBP450 million ($606 million) vaccine plant in the UK city of Liverpool, citing timing issues and a reduction in subsidies offered by the government. The move "was the big clue that it was losing patience with the UK government," said Mould. AstraZeneca reported a first-quarter profit rise of over 30 percent in April, noting that 40 percent of its revenue was generated in the US.
